Hangzhou Tigermed Consulting Co., Ltd

XSEC:300347 Stock Report

Market Cap: CN¥48.7b

Hangzhou Tigermed Consulting Future Growth

Future criteria checks 3/6

Hangzhou Tigermed Consulting is forecast to grow earnings and revenue by 35.5% and 13.3% per annum respectively. EPS is expected to grow by 35.3% per annum. Return on equity is forecast to be 8.4% in 3 years.

Key information

35.5%

Earnings growth rate

35.3%

EPS growth rate

Life Sciences earnings growth31.8%
Revenue growth rate13.3%
Future return on equity8.4%
Analyst coverage

Good

Last updated26 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300347 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20269,6022,2581,6562,16320
12/31/20258,4341,9271,6071,95222
12/31/20246,9911,2911,2141,62613
9/30/20246,8019596781,057N/A
6/30/20247,0311,129594953N/A
3/31/20247,2401,6919241,266N/A
12/31/20237,3842,0258371,150N/A
9/30/20237,3302,2818661,205N/A
6/30/20237,2022,2039641,373N/A
3/31/20237,0722,0576131,083N/A
1/1/20237,0852,0079091,358N/A
9/30/20227,2252,6981,0981,521N/A
6/30/20226,7512,8119171,299N/A
3/31/20226,1292,9371,1891,489N/A
1/1/20225,2142,8741,0551,424N/A
9/30/20214,2872,2139301,210N/A
6/30/20213,7972,0069761,263N/A
3/31/20213,4441,9508951,148N/A
12/31/20203,1921,750842999N/A
9/30/20203,0731,632558704N/A
6/30/20202,9181,488524621N/A
3/31/20202,845951452565N/A
12/31/20192,803842425528N/A
9/30/20192,737682386518N/A
6/30/20192,605606356450N/A
3/31/20192,436522387488N/A
12/31/20182,301472431522N/A
9/30/20182,107419458521N/A
6/30/20181,977400N/A404N/A
3/31/20181,805354N/A312N/A
12/31/20171,687301N/A315N/A
9/30/20171,500241N/A272N/A
6/30/20171,352182N/A281N/A
3/31/20171,255144N/A305N/A
12/31/20161,175141N/A192N/A
9/30/20161,150145N/A176N/A
6/30/20161,096159N/A156N/A
3/31/20161,015161N/A135N/A
12/31/2015957156N/A186N/A
9/30/2015862151N/A98N/A
6/30/2015821147N/A100N/A
3/31/2015725135N/A87N/A
12/31/2014625125N/A44N/A
9/30/2014510112N/A46N/A
6/30/2014401102N/A59N/A
3/31/201437799N/A57N/A
12/31/201333794N/A77N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300347's forecast earnings growth (35.5% per year) is above the savings rate (2.8%).

Earnings vs Market: 300347's earnings (35.5% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 300347's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300347's revenue (13.3% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 300347's revenue (13.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300347's Return on Equity is forecast to be low in 3 years time (8.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y